Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Cogent Biosciences

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$5.56B
Market cap · Apr/2026

Investors

18 investors on Cogent Biosciences's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 18 investors entered at this stage
Adage Capital
Wellington Management
Perceptive Advisors
Jennison Associates
Cowen Group
Janus Health Technologies
Commodore Capital
TCGX
Fairmount Funds Management
Sanofi Ventures
Venrock
Redmile Group
New Leaf Venture Partners
F-Prime
Deerfield
Seagen
Sectoral Asset Management
Novo Seeds

Global footprint

Where Cogent Biosciences has talent and traffic

Web traffic by country
17K monthly visits
across markets
🇺🇸 United States47.1%
🇮🇳 India15.3%
🇫🇷 France10%
🇨🇦 Canada8.2%
🇯🇵 Japan7.1%
Top 5 markets shown

See Cogent Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo